BioSpace News Archive

Werewolf Therapeutics, Inc., an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body’s immune system for the treatment of cancer, provided a business update and reported financial results for the quarter ended September 30, 2021.

BeyondSpring Pharmaceuticals, a clinical stage biopharmaceutical company focused on the development of innovative cancer therapeutics, announced the appointment of Mark Santos, RPh, to its Board of Directors, effective immediately.

BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, announced its financial results for the third quarter ended September 30, 2021 and provided an update on key strategic initiatives.

Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), today announced financial results for the third quarter ended September 30, 2021 and highlighted recent corporate accomplishments.

Sotera Health Company, a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, announced financial results for the third quarter and first nine months of 2021.

Synlogic, Inc., a clinical-stage company bringing the transformative potential of synthetic biology to medicine, reported financial results for the third quarter ended September 30, 2021 and provided an update on clinical programs.

Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced presentation of new data from the company’s clinical development program for phenylketonuria (PKU) during the 14th International Congress of Inborn Errors of Metabolism Meeting being held in Sydney, Australia November 21-24, 2021.

Sutro Biopharma, Inc. (NASDAQ: STRO), today reported its financial results for the quarter ended September 30, 2021, its recent business highlights, and a preview of anticipated select milestones in the remainder of 2021.

Castle Biosciences, Inc. announced that Derek Maetzold, president and chief executive officer, and Frank Stokes, chief financial officer, are scheduled to present a company overview at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum on Thursday, Nov. 18, 2021, at 9:30 a.m. Eastern time.

AVEO Oncology, a commercial stage, oncology-focused biopharmaceutical company, announced that members of its senior management team will participate in two upcoming virtual investor conferences.